<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Soul of Biotech &#187; marketing</title>
	<atom:link href="http://www.thesoulofbiotech.com/category/marketing/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thesoulofbiotech.com</link>
	<description>Laughter is the best medicine -- but let's cure cancer anyway.</description>
	<lastBuildDate>Mon, 30 Jan 2012 23:45:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Update: More about non-personal promotion</title>
		<link>http://www.thesoulofbiotech.com/2008/12/24/update-more-about-non-personal-promotion/</link>
		<comments>http://www.thesoulofbiotech.com/2008/12/24/update-more-about-non-personal-promotion/#comments</comments>
		<pubDate>Thu, 25 Dec 2008 02:59:31 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[marketing]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=86</guid>
		<description><![CDATA[Last year, I wrote about the future of non-personal promotion (NPP), and mentioned FluFlix, a YouTube contest encouraging the public to create ads about the flu. Well, while I wasn&#8217;t looking, Novartis, which also owns Excedrin, created another contest, this time about a new Excedrin formulation. Furthermore, according to Online Media Daily, the contest has [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2008/12/24/update-more-about-non-personal-promotion/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What happens when you dip your pharma brand into social media?</title>
		<link>http://www.thesoulofbiotech.com/2008/07/07/what-happens-when-you-dip-your-pharma-brand-into-social-media/</link>
		<comments>http://www.thesoulofbiotech.com/2008/07/07/what-happens-when-you-dip-your-pharma-brand-into-social-media/#comments</comments>
		<pubDate>Tue, 08 Jul 2008 01:38:30 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[enbrel]]></category>
		<category><![CDATA[marketing]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2008/07/07/what-happens-when-you-dip-your-pharma-brand-into-social-media/</guid>
		<description><![CDATA[I&#8217;ve been thinking about non-personal promotion a bit more since my previous post on Novartis&#8217; FluFlix contest. A casual search of Facebook for the top ten best-selling pharmaceutical brands of 2006 reveals that social groups already exist for most: Lipitor Advair Plavix Nexium Norvasc Remicade Enbrel Zyprexa Diovan Risperdal Primarily, these groups seem to provide [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2008/07/07/what-happens-when-you-dip-your-pharma-brand-into-social-media/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Republican Party borrows its new slogan from Effexor</title>
		<link>http://www.thesoulofbiotech.com/2008/05/19/republican-party-borrows-its-new-slogan-from-effexor/</link>
		<comments>http://www.thesoulofbiotech.com/2008/05/19/republican-party-borrows-its-new-slogan-from-effexor/#comments</comments>
		<pubDate>Tue, 20 May 2008 00:51:04 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[enbrel]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[advertising]]></category>
		<category><![CDATA[effexor]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2008/05/19/republican-party-borrows-its-new-slogan-from-effexor/</guid>
		<description><![CDATA[You may have already heard that the Republican party recently announced a new motto: &#8220;The Change You Deserve.&#8221; Politics aside, some brouhaha has been made of the fact that this slogan is already in use by Wyeth&#8217;s Effexor antidepressant. High comedy, of course. In fact, Pharmalot, one of my favorite pharma blogs, wondered if Wyeth [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2008/05/19/republican-party-borrows-its-new-slogan-from-effexor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What might the future of non-personal promotion look like?</title>
		<link>http://www.thesoulofbiotech.com/2007/10/04/what-might-the-future-of-non-personal-promotion-look-like/</link>
		<comments>http://www.thesoulofbiotech.com/2007/10/04/what-might-the-future-of-non-personal-promotion-look-like/#comments</comments>
		<pubDate>Thu, 04 Oct 2007 08:04:23 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[marketing]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/10/04/what-might-the-future-of-non-personal-promotion-look-like/</guid>
		<description><![CDATA[I&#8217;ve got my nose in binders and CD-ROMs about treatments for psoriasis and psoriatic arthritis, so I won&#8217;t be able to write quite as lengthy posts as I&#8217;d like, at least until I get my feet under me in my new role. Recently, however, a news item passed my virtual desk that I couldn&#8217;t resist [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/10/04/what-might-the-future-of-non-personal-promotion-look-like/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>&#8220;Big Bucks, Big Pharma&#8221;</title>
		<link>http://www.thesoulofbiotech.com/2007/08/10/big-bucks-big-pharma/</link>
		<comments>http://www.thesoulofbiotech.com/2007/08/10/big-bucks-big-pharma/#comments</comments>
		<pubDate>Sat, 11 Aug 2007 05:43:32 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[marketing]]></category>
		<category><![CDATA[movie]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[sicko]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/08/10/big-bucks-big-pharma/</guid>
		<description><![CDATA[Last week, I watched Big Bucks, Big Pharma, which is more or less what SiCKO would have been if Michael Moore had focused on pharmaceutical marketing, although BBBP&#8217;s criticisms are much more well-reasoned and well-researched. In fact, many of its facts are more or less right, although I question some of the business interpretations. For [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/08/10/big-bucks-big-pharma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What does genetic screening mean for the drug industry?</title>
		<link>http://www.thesoulofbiotech.com/2007/06/23/what-does-genetic-screening-mean-for-the-drug-industry/</link>
		<comments>http://www.thesoulofbiotech.com/2007/06/23/what-does-genetic-screening-mean-for-the-drug-industry/#comments</comments>
		<pubDate>Sat, 23 Jun 2007 07:51:54 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[marketing]]></category>
		<category><![CDATA[nytimes]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[sales]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2007/06/23/what-does-genetic-screening-mean-for-the-drug-industry/</guid>
		<description><![CDATA[My friend Lexi sent me a link to a NYT article that discusses personalized medicine (also known as pharmacogenomics), which is an area of great interest to me. It&#8217;s what I focused on in my master&#8217;s work, and it&#8217;s an area that, given the right opportunity, I intend to start a biotech in one day. [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2007/06/23/what-does-genetic-screening-mean-for-the-drug-industry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1328339706.534 seconds -->

